Listen to Guy Sauvageau’s interview at the ESH 5th International Conference on AML
Click on Guy Sauvageau’s interview last october on why should we target RUNX1 in AML treatment.
Click on Guy Sauvageau’s interview last october on why should we target RUNX1 in AML treatment.